Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Return on Assets (2017 - 2025)

Historic Return on Assets for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to 0.25%.

  • Anaptysbio's Return on Assets rose 1100.0% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.31% for FY2024, which is 0.0% changed from last year.
  • Per Anaptysbio's latest filing, its Return on Assets stood at 0.25% for Q3 2025, which was up 1100.0% from 0.35% recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Return on Assets registered a high of 0.02% during Q3 2021, and its lowest value of 0.41% during Q2 2024.
  • Its 5-year average for Return on Assets is 0.22%, with a median of 0.24% in 2023.
  • Its Return on Assets has fluctuated over the past 5 years, first skyrocketed by 2100bps in 2021, then tumbled by -2100bps in 2022.
  • Anaptysbio's Return on Assets (Quarter) stood at 0.11% in 2021, then tumbled by -66bps to 0.18% in 2022, then tumbled by -94bps to 0.34% in 2023, then increased by 12bps to 0.3% in 2024, then rose by 17bps to 0.25% in 2025.
  • Its Return on Assets was 0.25% in Q3 2025, compared to 0.35% in Q2 2025 and 0.31% in Q1 2025.